CELZ
Creative Medical Technology Holdings Inc
NASDAQ: CELZ · HEALTHCARE · BIOTECHNOLOGY
$2.25
+1.35% today
Updated 2026-04-30
Market cap
$8.50M
P/E ratio
—
P/S ratio
1,417.06x
EPS (TTM)
$-2.52
Dividend yield
—
52W range
$2 – $6
Volume
0.1M
Creative Medical Technology Holdings Inc (CELZ) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |